OLD Republic International Corp Sells 198,000 Shares of Cardinal Health, Inc. $CAH

OLD Republic International Corp reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 52.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 177,000 shares of the company’s stock after selling 198,000 shares during the quarter. OLD Republic International Corp’s holdings in Cardinal Health were worth $36,374,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Aventura Private Wealth LLC bought a new stake in shares of Cardinal Health in the 4th quarter valued at about $25,000. Elyxium Wealth LLC bought a new stake in shares of Cardinal Health in the 4th quarter valued at about $34,000. Barnes Dennig Private Wealth Management LLC increased its stake in shares of Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after acquiring an additional 53 shares during the last quarter. JPL Wealth Management LLC bought a new stake in shares of Cardinal Health in the 3rd quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. bought a new stake in shares of Cardinal Health in the 3rd quarter valued at about $31,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Down 0.1%

Shares of NYSE CAH opened at $200.42 on Friday. The company has a fifty day moving average price of $205.21 and a 200 day moving average price of $208.69. The firm has a market cap of $46.94 billion, a PE ratio of 30.64, a PEG ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 1.0%. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CAH shares. Evercore lowered their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Morgan Stanley upped their price target on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Wells Fargo & Company lowered their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. JPMorgan Chase & Co. decreased their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday, May 4th. Finally, Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.